Journal of Biological Regulators and Homeostatic Agents

Aims & Scope

Journal of Biological Regulators & Homeostatic Agents (IF 1.397) is a peer-reviewed journal published every 2 months.

The journal publishes original papers describing research in the fields of experimental and clinical medicine, molecular biology, biochemistry, regulatory molecules, cellular immunology and pharmacology.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	0.193

Quartile

Year	Value
2024	Q4

h-index

Year	Value
2024	58

Impact Factor

Year	Value
2024	0.80

Journal Rank

Year	Value
2024	21638

Journal Citation Indicator

Year	Value
2024	574

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by COVID-19: anti-inflammatory strategies.

  Citation: 101

  Authors: Pio

• Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.

  Citation: 16

  Authors: P.

• The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem

  Citation: 14

  Authors: P.

• Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.

  Citation: 9

  Authors: P.

• Expression changes of inflammatory cytokines TNF-α, IL-1β and HO-1 in hematoma surrounding brain areas after intracerebral hemorrhage.

  Citation: 6

  Authors: X.W.

• COVID-19 and Multisystem Inflammatory Syndrome, or is it mast cell activation syndrome?

  Citation: 6

  Authors: T.C.

• Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.

  Citation: 6

  Authors: S.K.

• Effectiveness of neurolinguistic programming in reducing anxiety and phobia.

  Citation: 5

  Authors: J-R.

• The role of miR-145 in promoting the fibrosis of pulmonary fibroblasts.

  Citation: 4

  Authors: T.

• How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and lung inflammation mediated by IL-1.

  Citation: 4

  Authors: P.

---